Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Mammomat Fusion full-field digital mammography (FFDM) system.
The unit features a new cesium-iodide digital detector, with a layered configuration of the photo diodes within the detector that enables more utilization of the radiation dose, Siemens said. This provides a patient dose that is equal to or below the range of other FFDM systems, and patients with breast thickness greater than 50 mm receive an even lower dose.
Mammomat Fusion also has a matrix of 23 x 30 cm, Siemens' OpDose feature, and a syngo-based acquisition workstation. Users can load patient data directly from a RIS without a second workstation, according to the company.
